Cell Signaling · Skim version

Nuclear Receptors: Receptors That Are Transcription Factors

About 1 min to skim · 3 figures

Read the full lesson → Skim the whole course →

The guiding idea

What does a cell do with a hormone that goes straight through its membrane?

Steroid and thyroid hormones act through receptors inside the cell that are themselves transcription factors.

  1. The idea: the hormone goes in, and its receptor reads DNA

  2. One plan, forty-eight receptors

    AI-generated illustration: a nuclear receptor drawn as a bar of four segments, a variable front end carrying AF-1, a DNA-binding domain holding two zinc ions, a hinge, and a hormone-binding domain carrying AF-2, with an inset of the hormone pocket. Below, two copies of the receptor face each other on DNA over two half-sites separated by a short gap.
    Most of the 48 receptors share one plan: a variable front end with AF-1, a DNA-binding domain folded around two zinc ions, a hinge, and a hormone-binding domain that holds the hormone, pairs two receptors and carries AF-2. Most work in pairs, so their response element has two six-base halves. AI-generated illustration
  3. Two ways to wait for a hormone

    AI-generated illustration: two schematic examples of nuclear receptor regulation. On the left, a glucocorticoid receptor waits with Hsp90 chaperones in the cytoplasm; hormone binding rearranges the complex, which travels to the nuclear pore with chaperones still associated. Inside the nucleus, hormone-bound receptors shed their chaperones and form a pair on DNA. On the right, a thyroid hormone receptor and RXR remain on DNA as hormone binding replaces a co-repressor with a co-activator.
    Two examples of how nuclear receptors wait for hormone. The glucocorticoid receptor waits mostly in the cytoplasm with Hsp90 chaperones. Hormone binding rearranges the complex; the receptor enters the nucleus and sheds its chaperones, then pairs and binds DNA. The thyroid hormone receptor waits on DNA with RXR and a co-repressor; hormone binding replaces the co-repressor with a co-activator. This co-repressor model is best documented for thyroid hormone and retinoic acid receptors, rather than every RXR partner. These diagrams show the usual hormone-dependent routes. AI-generated illustration
  4. What the hormone changes: one helix closes

    AI-generated illustration: two schematic hormone-binding domains. With an agonist in the pocket, a hinged bar lies across the pocket mouth and completes a groove in which a helper protein's short rod rests. With an antagonist whose side arm sticks out of the pocket, the bar cannot close and lies in the groove itself, so the helper has nowhere to bind.
    The main moving part is the last helix of the hormone-binding domain. With an agonist it folds across the pocket like a lid and completes the groove a co-activator binds; in the tamoxifen structure a side chain keeps it out and the helix lies in the groove itself, so the groove is taken. AI-generated illustration
  5. Why it takes hours, and where it meets medicine

Read the full lesson → Skim the whole course →